Synaptic Deficits Are Rescued in the p25/Cdk5 Model of Neurodegeneration by the Reduction of beta-Secretase (BACE1)
Alzheimer's disease (AD) is the most common cause of dementia, and is characterized by memory loss and cognitive decline, as well as amyloid β (Aβ) accumulation, and progressive neurodegeneration. Cdk5 is a proline-directed serine/threonine kinase whose activation by the p25 protein has been im...
Main Authors: | Giusti-Rodriguez, Paola (Contributor), Gao, Jun (Contributor), Graff, Johannes (Contributor), Rei, Damien (Contributor), Soda, Takahiro (Contributor), Tsai, Li-Huei (Contributor) |
---|---|
Other Authors: | move to dc.description.sponsorship (Contributor), Whitaker College of Health Sciences and Technology (Contributor), Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences (Contributor), Picower Institute for Learning and Memory (Contributor) |
Format: | Article |
Language: | English |
Published: |
Society for Neuroscience,
2012-06-27T17:50:26Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
by: Vassar Robert
Published: (2012-02-01) -
The beta secretase BACE1 regulates the expression of insulin receptor in the liver
by: Paul J. Meakin, et al.
Published: (2018-04-01) -
Identification of beta-secretase (BACE1) substrates using quantitative proteomics.
by: Matthew L Hemming, et al.
Published: (2009-12-01) -
The Alzheimer's disease β-secretase enzyme, BACE1
by: Vassar Robert, et al.
Published: (2007-11-01) -
Beta-Secretase 1 Underlies Reactive Astrocytes and Endothelial Disruption in Neurodegeneration
by: María Victoria Chacón-Quintero, et al.
Published: (2021-05-01)